Myotonine (Bethanechol Chloride)

Bethanechol Chloride acts as a direct agonist at muscarinic M3 receptors located on smooth‑muscle cells of the bladder and gut. By activating these G‑protein‑coupled receptors, it raises intracellular calcium levels, causing contraction of the detrusor muscle and intestinal smooth muscle, which enhances urinary flow and promotes intestinal peristalsis.

The dosage of Myotonine is individualized by the prescribing clinician based on the patient’s condition, age, renal function, and response to therapy. The prescriber determines the appropriate strength, frequency, and duration, and adjustments are made according to therapeutic effect and tolerability.

Safety data for Bethanechol Chloride in pregnancy and lactation are limited. The drug should only be used if the potential benefit justifies any possible risk to the fetus or infant. Healthcare providers should evaluate each case carefully and discuss potential risks with the patient.

To order Myotonine, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements) and the necessary import documentation.

Alternative agents for bladder stimulation include anticholinergic antagonists and catheterisation, while gastrointestinal motility can be supported by agents such as metoclopramide. Bethanechol’s advantage lies in its direct muscarinic agonism, which specifically enhances smooth‑muscle contraction without significant central nervous system effects, but it may have a higher incidence of cholinergic side effects compared with some alternatives.

Myotonine should be stored at ambient temperature, preferably below 25 °C. Keep the product in its original packaging, protect it from moisture and direct sunlight, and ensure the container is tightly closed to maintain stability throughout its shelf life.

Myotonine is administered orally as a tablet or liquid preparation, as directed by the prescriber. It is taken with or without food, according to the dosing schedule provided, and patients should follow the exact instructions on timing and any required fluid intake.

The most serious adverse reactions include bradycardia, severe hypotension, bronchospasm, and allergic responses such as rash or swelling. Patients should be instructed to seek immediate medical attention if they experience rapid heart rate slowing, faintness, difficulty breathing, or signs of an allergic reaction.

Myotonine is contraindicated in patients with known hypersensitivity to Bethanechol or other muscarinic agonists, severe bradyarrhythmias, recent myocardial infarction, uncontrolled asthma, or significant obstructive pulmonary disease. Caution is also advised in individuals with renal failure, as dose adjustment may be required.